4//SEC Filing
Curley Joanne 4
Accession 0001209191-22-061178
CIK 0001831828other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:08 PM ET
Size
20.3 KB
Accession
0001209191-22-061178
Insider Transaction Report
Form 4
Curley Joanne
Chief Development Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-12-12$11.00/sh+6,900$75,900→ 33,721 total - Sale
Class A Common Stock
2022-12-13$18.28/sh−11,733$214,441→ 26,821 total - Sale
Class A Common Stock
2022-12-13$18.19/sh−1,078$19,609→ 26,821 total - Sale
Class A Common Stock
2022-12-12$18.25/sh−6,900$125,924→ 26,821 total - Exercise/Conversion
Class A Common Stock
2022-12-13$6.37/sh+1,078$6,870→ 27,899 total - Exercise/Conversion
Class A Common Stock
2022-12-13$11.00/sh+11,733$129,063→ 38,554 total - Exercise/Conversion
Stock Option (right to buy)
2022-12-13−11,733→ 65,384 totalExercise: $11.00Exp: 2031-05-12→ Class A Common Stock (11,733 underlying) - Exercise/Conversion
Stock Options (right to buy)
2022-12-12−6,900→ 77,117 totalExercise: $11.00Exp: 2031-05-12→ Class A Common Stock (6,900 underlying) - Exercise/Conversion
Stock Options (right to buy)
2022-12-13−1,078→ 8,639 totalExercise: $6.37Exp: 2030-03-31→ Class A Common Stock (1,078 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.41, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.09 to $18.92, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]1/4 of the shares subject to the option vested on May 13, 2022, and 1/48 of the shares vest monthly thereafter.
- [F5]1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001857670
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 4:08 PM ET
- Size
- 20.3 KB